Lv1
44 积分 2022-09-22 加入
Future Considerations When Considering Partial Thymectomy
24天前
已完结
Thymectomy promotes maintained complete stable remission in myasthenia gravis
24天前
已完结
Association Between the Hemoglobin-to-Red Blood Cell Distribution Width Ratio and Perioperative Mortality Risk in Myasthenia Gravis Patients with Sepsis: A Retrospective Cohort Study
24天前
已完结
Perioperative Administration of Efgartigimod in myasthenia gravis patients with Thymoma: A six-case series
25天前
已完结
Rituximab in AChR and MusK Myasthenia Gravis: long-term follow-up with different therapeutic protocols
25天前
已完结
Gefurulimab—The First Effective Nanobody in Myasthenia Gravis Therapy
26天前
已完结
Efgartigimod in myasthenia gravis: Efficacy and steroid-sparing benefits in a real-world cohort
1个月前
已完结
Hsa_circ_0065149 mediates the ceRNA network pathway: Research on the mechanism regulating myasthenia gravis
1个月前
已完结
Pathogenic properties of myasthenia gravis AChR autoantibodies associate with clinical response to efgartigimod
1个月前
已完结
皖公网安备34019202002308
